Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in children and adolescents with Major Depressive Disorder
NCT00529789Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2007
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started Aug 2007; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00529789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00529789.